Registro:

Referencias:

• Satapathy, S.K., Sanyal, A.J., Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease (2015) Semin Liver Dis, 35, pp. 221-235
• Brunt, E.M., Histopathology of non-alcoholic fatty liver disease (2009) Clin Liver Dis, 13, pp. 533-544
• Sookoian, S., Pirola, C.J., The genetic epidemiology of nonalcoholic fatty liver disease: toward a personalized medicine (2012) Clin Liver Dis, 16, pp. 467-485
• Brunt, E.M., Wong, V.W., Nobili, V., Day, C.P., Sookoian, S., Maher, J.J., Bugianesi, E., Rinella, M.E., Nonalcoholic fatty liver disease (2015) Nat Rev Dis Primers, 1, p. 15080
• Murphy, S.K., Yang, H., Moylan, C.A., Pang, H., Dellinger, A., Abdelmalek, M.F., Garrett, M.E., Diehl, A.M., Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease (2013) Gastroenterology, 145, pp. 1076-1087
• Pirola, C.J., Gianotti, T.F., Burgueno, A.L., Rey-Funes, M., Loidl, C.F., Mallardi, P., Martino, J.S., Sookoian, S., Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease (2013) Gut, 62, pp. 1356-1363
• Pirola, C.J., Scian, R., Gianotti, T.F., Dopazo, H., Rohr, C., Martino, J.S., Castano, G.O., Sookoian, S., Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins (2015) Medicine (Baltimore), 94
• Sookoian, S., Rosselli, M.S., Gemma, C., Burgueno, A.L., Fernandez Gianotti, T., Castano, G.O., Pirola, C.J., Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter (2010) Hepatology, 52, pp. 1992-2000
• Zeybel, M., Hardy, T., Robinson, S.M., Fox, C., Anstee, Q.M., Ness, T., Masson, S., Mann, J., Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease (2015) Clin Epigenetics, 7, p. 25
• Chalasani, N., Guo, X., Loomba, R., Goodarzi, M.O., Haritunians, T., Kwon, S., Cui, J., Rotter, J.I., Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease (2010) Gastroenterology, 139, pp. 1567-1576
• Feitosa, M.F., Wojczynski, M.K., North, K.E., Zhang, Q., Province, M.A., Carr, J.J., Borecki, I.B., The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study (2013) Atherosclerosis, 228, pp. 175-180
• Kawaguchi, T., Sumida, Y., Umemura, A., Matsuo, K., Takahashi, M., Takamura, T., Yasui, K., Imai, Y., Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese (2012) PLoS One, 7
• Kitamoto, T., Kitamoto, A., Yoneda, M., Hyogo, H., Ochi, H., Nakamura, T., Teranishi, H., Sekine, A., Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan (2013) Hum Genet, 132, pp. 783-792
• Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B.G., Zhou, H.H., Tybjaerg-Hansen, A., Vogt, T., Cohen, J.C., Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease (2014) Nat Genet, 46, pp. 352-356
• Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L.A., Boerwinkle, E., Hobbs, H.H., Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease (2008) Nat Genet, 40, pp. 1461-1465
• Sookoian, S., Pirola, C.J., Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease (2011) Hepatology, 53, pp. 1883-1894
• Pirola, C.J., Sookoian, S., The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis (2015) Hepatology, 62, pp. 1742-1756
• Sookoian, S., Flichman, D., Scian, R., Rohr, C., Dopazo, H., Fernandez Gianotti, T., San Martino, J., Pirola, C.J., Mitochondrial genome architecture in non-alcoholic fatty liver disease (2016) J Pathol, 240, pp. 437-449
• Sookoian, S., Pirola, C.J., Nonalcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis (2016) Hepatology, 64, pp. 1417-1420
• Hindorff, L.A., Sethupathy, P., Junkins H, A., Ramos, E.M., Mehta, J.P., Collins, F.S., Manolio, T.A., Potential etiologic and functional implications of genome-wide association loci for human diseases and traits (2009) Proc Natl Acad Sci USA, 106, pp. 9362-9367
• Iyer, M.K., Niknafs, Y.S., Malik, R., Singhal, U., Sahu, A., Hosono, Y., Barrette, T.R., Dhanasekaran, S.M., The landscapeof long noncoding RNAs in the human transcriptome (2015) Nat Genet, 47, pp. 199-208
• Cabili, M.N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A., Rinn, J.L., Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses (2011) Genes Dev, 25, pp. 1915-1927
• Matteoni, C.A., Younossi, Z.M., Gramlich, T., Boparai, N., Liu, Y.C., McCullough, A., Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity (1999) Gastroenterology, 116, pp. 1413-1419
• Pirola, C.J., Fernandez Gianotti, T., Castano, G.O., Mallardi, P., San Martino, J., Mora Gonzalez Lopez Ledesma, M., Flichman, D., Sookoian, S., Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis (2015) Gut, 64, pp. 800-812
• Mann, D.A., Smart, D.E., Transcriptional regulation of hepatic stellate cell activation (2002) Gut, 50, pp. 891-896
• Sookoian, S., Castano, G., Gemma, C., Gianotti, T.F., Pirola, C.J., Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease (2007) World J Gastroenterol, 13, pp. 4242-4248
• Sookoian, S., Castano, G., Gianotti, T.F., Gemma, C., Rosselli, M.S., Pirola, C.J., Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease (2008) Cytokine, 44, pp. 201-206
• Speliotes, E.K., Yerges-Armstrong, L.M., Wu, J., Hernaez, R., Kim, L.J., Palmer, C.D., Gudnason, V., Mitchell, B.D., Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits (2011) PLoS Genet, 7
• Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., Ferrell, L.D., Sanyal, A.J., Design and validation of a histological scoring system for nonalcoholic fatty liver disease (2005) Hepatology, 41, pp. 1313-1321
• Brunt, E.M., Kleiner, D.E., Wilson, L.A., Belt, P., Neuschwander-Tetri, B.A., Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings (2011) Hepatology, 53, pp. 810-820
• Maher, B., ENCODE: The human encyclopaedia (2012) Nature, 489, pp. 46-48
• Bernstein, B.E., Stamatoyannopoulos, J.A., Costello, J.F., Ren, B., Milosavljevic, A., Meissner, A., Kellis, M., Lander, E.S., The NIH Roadmap Epigenomics Mapping Consortium (2010) Nat Biotechnol, 28, pp. 1045-1048
• Skol, A.D., Scott, L.J., Abecasis, G.R., Boehnke, M., Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies (2006) Nat Genet, 38, pp. 209-213
• Sookoian, S., Castano, G.O., Scian, R., Mallardi, P., Fernandez Gianotti, T., Burgueno, A.L., San Martino, J., Pirola, C.J., Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity (2015) Hepatology, 61, pp. 515-525

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------